Decision Resources Group Acquires Pinsonault
April 17, 2012—Burlington, Mass. and Mt. Olive, NJ—Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired Pinsonault, a leading provider in offering managed markets-specific business and training solutions to the pharmaceutical and biotech industries. The acquisition of Mt. Olive, NJ-based Pinsonault by Burlington, Mass.-based Decision Resources Group will result in a significant expansion of Decision Resources Group’s Market Access Business Unit which currently includes Fingertip Formulary, HealthLeaders-InterStudy and PharmaStrat.
Jim Lang, who was appointed President of the Market Access Business Unit at Decision Resources Group in January of 2012, will head up the integration of the Pinsonault brand. Mr. Lang was the President of IHS Cambridge Energy Research Associates (IHS CERA), a recognized leader in energy industry subscription information products, advisory services and events. Prior to IHS CERA, he was President of Strategic Decisions Group (SDG), a leading global strategy consultancy, spending 17 years advising a wide range of Global 1000 companies. After a successful management buyout in 2000, Jim led the firm through solid growth and a successful restructurings/sale in 2006 when SDG’s largest Life Sciences practice was sold to IMS Health. Most recently, Mr. Lang has been an active private investor and advisor, providing seed and growth capital to a dozen companies in the healthcare, clean tech and business services space, and serving on a number of boards.
Regarding the purchase, Mr. Lang said, “This acquisition is another example of how Decision Resources Group is bringing together the best-in-class brands in a way that allows our clients to leverage these premier offerings to suit their unique business needs. Pinsonault’s renowned reputation for quality and customer service makes it a brand we are excited to see added to our portfolio.”
Pinsonault serves its clients with three business lines: business solutions that include a suite of data and analytic tools to support managed markets marketing and sales staff; managed markets training that offers the leading online training program for biopharma companies looking to improve business activities within the managed market space; and events and research which include the well-known and well-attended bi-annual Managed Markets Summits.
“We are excited to begin our next surge of growth as a brand within the Decision Resources Group family,” said Christian Pinsonault, Managing Partner at Pinsonault. “With our unique and proven training solutions for selling and marketing into the managed markets space as well as our highly attended conferences, we feel we can add a new dimension to the services that Decision Resources Group currently offers.”
“The opportunity our employees and our brand now have as part of the Decision Resources Group family is tremendous,” added Tony Pinsonault, Managing Partner at Pinsonault. “Our 16 years in the business has taught us to wisely choose who to partner with and we are thrilled that Decision Resources Group has the confidence in us to bring us into their fold.”
Pinsonault will remain headquartered in Mt. Olive, NJ.
Pinsonault is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries. The organization strives to create customer specific solutions that provide valuable strategic insight and results oriented tactical tools enabling clients to identify and capitalize on Managed Markets business opportunities. For more information about Pinsonault, please visit www.Pinsonault.com.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry. Clients rely on this analysis, data and consulting services to make more informed critical management decisions. With over 450 employees worldwide, analysts at Decision Resources Group companies provide the pharmaceutical, biotech, medical device, financial services and managed care industries with the analytics and advice they need to compete and thrive in an increasingly competitive marketplace. Through both organic growth and an aggressive acquisition strategy, Decision Resources Group has become the premier provider of healthcare analysis, data and advisory services in the world. Visit Decision Resources Group at www.DecisionResourcesGroup.com.